US2018235962A1PendingUtilityA1
Acoustic mixing for auto granulation
Est. expiryJul 7, 2035(~8.9 yrs left)· nominal 20-yr term from priority
Inventors:Ping X. GaoRaimundo HoJayanthy JayanthSamrat MukherjeeKatherine E. PetersonJohn StrongPing TongGeoff G. Zhang
A61J 3/02B01F 2215/0032A61K 31/505A61K 9/1688B01F 11/02A61K 31/513B01F 2101/22B01F 31/80
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A process for acoustically mixing a bulk drug substance involves the application of acoustic energy to drive an accelerative force in a mixing vessel containing the drug substance. The drug substance may be, for example, Elagolix.
Claims
exact text as granted — not AI-modified1 . A process comprising acoustically mixing a bulk drug substance wherein said acoustic mixing comprises the application of acoustic energy to drive an accelerative force in a mixing vessel containing the drug substance.
2 . The process according to claim 1 wherein said acoustic mixing comprises the application of an accelerative force to the mixing vessel of greater than 10 G force.
3 . The process of claim 4 wherein said accelerative force is greater than 20 G.
4 . The process of claim 5 wherein said accelerative force is greater than 40 G.
5 . The process of claim 6 wherein said accelerative force is greater than 60 G.
6 . The process of claim 7 wherein said accelerative force is greater than 80 G.
7 . The process according to claim 1 wherein said drug substance comprises an amorphous solid.
8 . The process according to claim 1 wherein said drug substance has a flowability constant of less than 5.
9 . The process according to claim 1 wherein said drug substance has a flowability constant of less than 2.
10 . The process according to claim 1 wherein prior to acoustic mixing, the drug substance has a flowability constant of less than 2 and subsequent to mixing greater than 2.
11 . The process according to claim 1 wherein prior to acoustic mixing, the drug substance has a flowability constant of less than 1 and subsequent to mixing greater than 1.
12 . The process according to claim 1 wherein the flowability constant is increased by at least 0.1.
13 . The process according to claim 1 wherein the flowability constant is increased by at least 0.2.
14 . The process according to claim 1 wherein the flowability constant is increased by at least 0.3.
15 . The process according to claim 1 wherein the flowability constant is increased by at least 0.4.
16 . The process according to claim 1 wherein the flowability constant is increased by at least 0.5.
17 . The process according to claim 1 wherein prior to acoustic mixing said drug substance has a bulk density of less than 0.4 g/ml.
18 . The process according to claim 1 wherein prior to acoustic mixing, the drug substance has a volume-averaged particle size DV10 of less than 100 um.
19 . The process according to claim 1 wherein acoustic mixing of the drug substance increases the volume-averaged particle size DV10 by at least 10 um.
20 . The process according to claim 1 wherein said drug substance is elagolix.Join the waitlist — get patent alerts
Track US2018235962A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.